All CEACAM6 reagents are produced in house and quality controlled, including 19 CEACAM6 Antibody, 3 CEACAM6 ELISA, 13 CEACAM6 Gene, 1 CEACAM6 Lysate, 1 CEACAM6 Protein, 1 CEACAM6 qPCR. All CEACAM6 reagents are ready to use.
Recombinant CEACAM6 proteins are expressed by HEK293 Cells with fusion tags as C-His.
CEACAM6antibodies are validated with different applications, which are WB, ELISA, FCM, ICC/IF, IF, ELISA(Det), IHC-P, ELISA(Cap).
CEACAM6cDNA clones are full length sequence confirmed and expression validated. There are 13 kinds of tags for each CEACAM6 of different species, especially GFP tag, OFP tag, FLAG tag and so on. There are three kinds of vectors for choice, cloning vector, expression vector and lentivrial expression vector.
CEACAM6ELISA Kit are quality controlled by 8 internation QC standard which guarantee every ELISA Kit with high quality.
Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6), also known as nonspecific crossreacting antigen (NCA) and CD66c, is one of seven human CEACAM family members within the immunoglobulin superfamily. It s a glycosylphosphatidylinositol-linked immunoglobulin superfamily member that is overexpressed in a variety of human cancers, including colon, breast and lung and is associated with tumourigenesis, tumour cell adhesion, invasion and metastasis. CEACAM6 is a unique mediator of migration and invasion of drug resistant oestrogen-deprived breast cancer cells, and this protein could be an important biomarker of metastasis. CEACAM6 is expressed by granulocytes and their progenitors. It is also expressed by epithelia of various organs and is upregulated in pancreatic and colon adenocarcinomas, as well as hyperplastic polyps. Resistance to adhesion-related apoptosis in tumor cells is conferred in the condition of CEACAM6 overexpression.